Bushnell, DA, Bodeker KL, O’Dorisio TM, Madsen M, Menda Y  Graves , Zamba KD, O’Dorisio MS. Addition Of 131I MIBG To PRRT (90Y DOTATOC) For Personalized Treatment of Selected Patients with Neuroendocrine Tumors. Journal of Nuclear Medicine. 2020; In Press

Li M, Sagastume EA, Lee D, McAlister D, DeGraffenreid AJ, Olewine KR, Graves S, Copping R, Mirzadeh S, Zimmerman BE, Larsen RH, Johnson FL, Schultz MK. 203/212 Pb Theranostic Radiopharmaceuticals for Image-guided Radionuclide Therapy for Cancer. Curr Med Chem 2020; 27: 7003-7031

Kunos C, Mankoff D, Schultz K, Graves S,  and Pryma D. Radiopharmaceutical Chemistry and Drug Development—What’s Changed?  Seminars in Radiation Oncology. 2020; 31: 3-11.

Kloepping K, Kraus A, Hedlund DK, Gnade CM, Wagner BA, McCormick ML, Fath MA, Seol D, Lim TH, Buettner GR, Goswami PC, Pigge FC, Spitz DR, Schultz MK. Triphenylphosphonium derivatives disrupt metabolism and inhibit melanoma growth in vivo when delivered via a thermosensitive hydrogel. PLoS One. 2020 Dec 30;15(12):e0244540. doi: 10.1371/journal.pone.0244540. eCollection 2020.